The health industry and medical technology are among the sectors with great future potential and promise attractive growth and market opportunities for companies and investors. Saxony is excellently positioned for this.
Industries / Life Sciences
More than 6,300 foreign companies are located in Baden-Württemberg. THE LÄND boasts innovative strength, a diverse range of industries, research institutions with close links to business as well as highly trained specialist staff. Thanks to these factors, it continues to be an attractive location for international investors as one of Germany’s and Europe’s most powerful economic centres, even during times of crisis.
Around 8 million euros were invested by foreign companies in the federal state of Bremen in 2022. The northern German city scored particularly well in the technology sector, but also in the transport and logistics sector.
Subsea Europe Services, founded around three years ago in Halstenbek in Schleswig-Holstein, set up another location at the Ocean Technology Campus (OTC) in Rostock in summer 2022.
As part of the expansion phase of its Medicine Information Technology Initiative (MII), the German government will be putting some EUR 200 million into data-based health research. The funds will be allocated between now and 2026.
Throughout 2022, this website featured more than 300 articles and videos about Germany as a business and high-tech location. Below is a list so that you can catch up on anything you might have missed.
Researchers at the Max Planck Institute for Multidisciplinary Sciences and the Institute for Auditory Neuroscience in Göttingen have come up with a treatment for synaptic deafness in very young, hearing-impaired children.
It’s an innovation that fires the imagination and could have massive medical potential. Young Berlin company Cellbricks has successfully employed additive manufacturing to create simple, living human tissue.
American medtech provider Intuitive Surgical is expanding in a major way in the southwestern German city of Freiburg. The company has broken ground on a 28,700-square-meter site that will be home to a new production, training and distribution center.
The Association of Researching Pharmaceutical Companies (vfa) says 36 newly approved medications have been introduced to the German market in 2022. That continues the strong innovation trend from 2021, when 46 new medicines were introduced in the calendar year, vfa added.